2025-13449Notice

Missouri Pharma Firm Applies for Bulk Controlled Drug Production

Published Date: 7/17/2025

Notice

Summary

Curia Missouri Inc. wants to become a big-time maker of certain controlled drugs. This means they’ll be officially allowed to produce these substances in large amounts. If approved, this could affect companies and regulators keeping an eye on drug manufacturing, with no immediate cost changes announced.

No Economic Impacts Identified for this Document

Your PRIA Score

Score Hidden

Personalized for You

How does this regulation affect your finances?

Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.

Free to start

Key Dates

Published Date
7/17/2025

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register